Gallbladder Cancer Pipeline Drug Analysis and Overview of Companies Profiles in H1 2017 Gastrointestinal Stromal Tumor Pipeline guide defines Gastrointestinal stromal tumors (GISTs) as a malignant (cancer) or benign (not cancer). They are most common in the stomach and small intestine but may be found anywhere in or near the GI tract. Some scientists believe that GISTs begin in cells called interstitial cells of Cajal (ICC), in the wall of the GI tract. Gastrointestinal Stromal Tumor Pipeline Market Research Report provides the latest projects and drug profiles with key companies. Introduction: Gastrointestinal stromal tumors (GISTs) are tumors, which occur in the gastrointestinal tract. Gastrointestinal stromal tumors belong to a group of cancers called soft tissue sarcoma. GISTs can be benign or malignant tumors. The symptoms of GIST include pain or discomfort in the abdomen, a mass in the abdomen that can feel with the hand, nausea and vomiting, vomiting blood or having blood in the stool and fatigue due to anemia (low red blood cell counts). Gastrointestinal stromal tumor treatment involves the use of surgery, radiation therapy, targeted therapy and chemotherapy. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1057915 . The Pharmaceutical and Healthcare latest pipeline guide Gastrointestinal Stromal Tumor (GIST) Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Gastrointestinal Stromal Tumor (GIST) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Key Company Profiles: AB Science SA, Advanced Accelerator Applications SA, Advenchen Laboratories LLC, Ariad Pharmaceuticals Inc, Arog Pharmaceuticals Inc, ArQule Inc, Array BioPharma Inc, Astex Pharmaceuticals Inc, Blueprint Medicines Corp, Boston Biomedical Inc, Calithera Biosciences Inc, Celldex Therapeutics Inc, Chipscreen Biosciences Ltd, CytRx Corp, Deciphera Pharmaceuticals LLC, Exelixis Inc, F. Hoffmann-La Roche Ltd, Hanmi Pharmaceuticals Co Ltd, Horizon Pharma Plc, Immunicum AB, Jiangsu Hengrui Medicine Co Ltd, Natco Pharma Ltd, Nerviano Medical Sciences Srl, Novartis AG, Omeros Corp, Pharma Mar SA, Plexxikon Inc, Rhizen Pharmaceuticals SA, Taiho Pharmaceutical Co Ltd. Gastrointestinal Stromal Tumor Drug Profiles aldoxorubicin hydrochloride Drug Profile, amcasertib Drug Profile, apatinib Drug Profile, ARQ-
www.reportsnreports.com
Gallbladder Cancer Pipeline Drug Analysis and Overview of Companies Profiles in H1 2017 092 Drug Profile, binimetinib Drug Profile, BLU-285 Drug Profile, buparlisib hydrochloride Drug Profile, cabozantinib s-malate Drug Profile, CB-839 Drug Profile, CDX-0158 Drug Profile, CHMFLKIT-110 Drug Profile, crenolanib besylate Drug Profile, CS-2164 Drug Profile, dabrafenib mesylate + trametinib dimethyl sulfoxide Drug Profile, DCC-2618 Drug Profile, everolimus Drug Profile, HM-95573 Drug Profile, interferon gamma-1b Drug Profile, Intuvax Drug Profile, masitinib Drug Profile, nilotinib Drug Profile, NMSP-088 Drug Profile, NRCAN-019 Drug Profile, onalespib Drug Profile, Peptide to Antagonize GRPR for Oncology Drug Profile, pexidartinib Drug Profile, PLX-9486 Drug Profile, PM-184 Drug Profile, ponatinib hydrochloride Drug Profile, SF1126 Drug Profile, SHR-1020 Drug Profile, TAS-116 Drug Profile, TGR-1202 Drug Profile, vemurafenib, WBZ-4 Drug Profile. Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1057915 Gastrointestinal Stromal Tumor (GIST) (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Gastrointestinal Stromal Tumor (GIST) (Oncology). The pipeline guide reviews pipeline therapeutics for Gastrointestinal Stromal Tumor (GIST) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Gastrointestinal Stromal Tumor (GIST) (Oncology) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Gastrointestinal Stromal Tumor (GIST) (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule www.reportsnreports.com
Gallbladder Cancer Pipeline Drug Analysis and Overview of Companies Profiles in H1 2017 type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Gastrointestinal Stromal Tumor (GIST) (Oncology) Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1057915 . Table of Contents: Gastrointestinal Stromal Tumor Overview Gastrointestinal Stromal Tumor Therapeutics Development Gastrointestinal Stromal Tumor Pipeline Overview Gastrointestinal Stromal Tumor Pipeline by Companies Gastrointestinal Stromal Tumor Therapeutics Assessment Gastrointestinal Stromal Tumor Companies Involved in Therapeutics Development Gastrointestinal Stromal Tumor Drug Profiles Gastrointestinal Stromal Tumor Dormant Projects Gastrointestinal Stromal Tumor Product Development Milestones and more‌ List of Tables. Number of Products under Development for Gallbladder Cancer, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Advenchen Laboratories LLC, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Array BioPharma Inc, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Bayer AG, H1 2017 Gastrointestinal Stromal Tumor Pipeline by BeiGene Ltd, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Eli Lilly and Company, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Halozyme Therapeutics Inc, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Hutchison China MediTech Ltd, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Leap Therapeutics Inc, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Merrimack Pharmaceuticals Inc, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Novartis AG, H1 2017 Gastrointestinal Stromal Tumor Pipeline by NuCana BioMed Ltd, H1 2017 Gastrointestinal Stromal Tumor Pipeline by Threshold Pharmaceuticals Inc, H1 2017 Gastrointestinal Stromal Tumor Pipeline by VasGene Therapeutics Inc, H1 2017 Gastrointestinal Stromal Tumor Dormant Projects, H1 2017
www.reportsnreports.com
Gallbladder Cancer Pipeline Drug Analysis and Overview of Companies Profiles in H1 2017 About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with your contact details.
www.reportsnreports.com